Antoine Turzi, Founder & President of RegenLab group, Receives Prestigious EIB Innovation Champion Award
July 18 2024 - 11:08AM
Business Wire
RegenLab, a pioneering biotechnology company specializing in the
research, and manufacturing of patented cell and tissue engineering
medical devices, has been honoured with the “Innovation Champion
Award” by the European Investment Bank (EIB) at the Adventure Debt
Summit held at the European Convention Center in Luxembourg.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240716529298/en/
Antoine Turzi receives EU-EIB Innovation
Champion Award. Antoine Turzi, Founder and President of RegenLab,
pictured between two officials of the European Investment Bank.
(Photo: Business Wire)
This prestigious award recognizes RegenLab France’s commitment
to “reshoring” by establishing a state-of-the-art biotechnology
factory in Paris-Saclay and its innovative work on the “REGENMATRIX
PRP-HA”. This next-generation product combines Platelet-Rich Plasma
(PRP) with cross-linked Hyaluronic Acid (HA) in a single tube,
designed specifically to address the needs of patients with
advanced grade III-IV knee osteoarthritis. Currently, a clinical
study is underway in 16 university hospitals across France to
demonstrate the effectiveness and safety of this groundbreaking
treatment.
“We are honored and delighted to receive this award from the
European Investment Bank,” said Mr. Antoine Turzi, Founder &
President of RegenLab group. “This recognition celebrates the
successful completion of our French factory and our ongoing R&D
efforts. Our goal is to innovate in cell therapies that enhance the
well-being of patients.”
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240716529298/en/
RegenLab USA LLC | +1 (800) 220-9082 |
info@regenlabusa.com RegenLab France SAS | +33 1 77 44 60 60 |
info@regenlab.com Regen Lab SA | +41 21 864 01 11
| info@regenlab.com Antoine Turzi | President &
Founder